Home
>
National Drug Code (NDC)
>
Vermocks
Vermocks - 11096-001-01 - (Pyrantel Pamoate)
Drug Information of Vermocks
| Product NDC: | 11096-001 |
| Proprietary Name: | Vermocks |
| Non Proprietary Name: | Pyrantel Pamoate |
| Active Ingredient(s): | 144 mg/mL & nbsp; Pyrantel Pamoate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vermocks
| Product NDC: | 11096-001 |
| Labeler Name: | Tarmac Products, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part357B |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20120426 |
Package Information of Vermocks
| Package NDC: | 11096-001-01 |
| Package Description: | 30 mL in 1 BOTTLE (11096-001-01) |
NDC Information of Vermocks
| NDC Code | 11096-001-01 |
| Proprietary Name | Vermocks |
| Package Description | 30 mL in 1 BOTTLE (11096-001-01) |
| Product NDC | 11096-001 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Pyrantel Pamoate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20120426 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Tarmac Products, Inc. |
| Substance Name | PYRANTEL PAMOATE |
| Strength Number | 144 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
